Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes

Mei-ling Xuan; Chuan-jian Lu; Ling Han; Yu Xiang

doi:10.1007/s11655-014-1792-0

Your Location：

Home >

Browse articles >

Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes

Updated：2021-08-27

- Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes
- Chinese Journal of Integrative Medicine Vol. 21, Issue 2, Pages: 108-114(2015)
- Affiliations：
  
  Department of Dermatology, Guangdong Provincial Hospital of Traditional Chinese Medicine,Guangzhou,China
- Author bio：
- Funds：
  
  Supported by the Financial Industry Technology Research and Development Program of Guangdong Province, China (No. 201105)
- DOI：10.1007/s11655-014-1792-0
  CLC：
- Published：2015，
  
  Published Online：19 December 2014，
Scan for full text
Xuan, Ml., Lu, Cj., Han, L. et al. Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes., Chin. J. Integr. Med. 21, 108–114 (2015). https://doi.org/10.1007/s11655-014-1792-0

Mei-ling Xuan, Chuan-jian Lu, Ling Han, et al. Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes. [J]. Chinese Journal of Integrative Medicine 21(2):108-114(2015)
Xuan, Ml., Lu, Cj., Han, L. et al. Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes., Chin. J. Integr. Med. 21, 108–114 (2015). https://doi.org/10.1007/s11655-014-1792-0 DOI：

Mei-ling Xuan, Chuan-jian Lu, Ling Han, et al. Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes. [J]. Chinese Journal of Integrative Medicine 21(2):108-114(2015) DOI： 10.1007/s11655-014-1792-0.

摘要

To investigate whether the serum levels of inflammation-related cytokines might be different between the healthy individuals and the psoriatic patients diagnosed of three varied Chinese medicine (CM) syndromes [blood-stasis syndrome (BSS)

blood-dryness syndrome (BDS) and wind-heat syndrome (WHS)]. A total of 62 psoriatic patients were recruited and assigned to 3 groups according to their CM syndromes

including 27 patients of BSS

21 of BDS and 14 of WHS. Another 20 sex- and age-matched healthy subjects were enrolled into the control group. Serum concentrations of multiple cytokines

including monocyte chemotactic protein-1 (MCP-1)

macrophage inflammatory protein-1α (MIP-1α)

soluble CD4O ligand (SCD40L)

tumor necrosis factor-α (TNF-α)

epidermal growth factor (EGF)

interleukin-8 (IL-8)

interleukin-17 (IL-17)

interferon γ inducible protein-10 (IP-10) and vascular endothelial growth factor (VEGF)

were measured by a multiplexed flow cytometric assay. The circulating levels of MIP-1α

TNF-α

IL-8

and IP-10 were significantly increased in the psoriatic patients compared with the healthy controls (P<0.01). Male and female patients tended to have higher serum levels of MCP-1 and IP-10

respectively (P<0.05). Interestingly

compared with the control group

6 out of the 9 cytokines (MCP-1

MIP-1α

TNF-α

EGF

IL-8 and IP-10) were substantially increased in the BSS group (P<0.05 or P<0.01)

whereas only MIP-1α and IL-8 levels were elevated in the BDS group (P<0.05 or P<0.01) concurrent with lowered concentrations of SCD40L and IL-17 (P<0.05). In the WHS group

MIP-1α was the only cytokine whose level was evidently increased (P<0.01)

in contrast to IL-17 which was decreased as compared with the control (P<0.05). The psoriatic patients overall owned higher levels of MIP-1α and IL-8 in the circulation which were comparable among the 3 groups of CM syndromes (P<0.01). In contrast

TNF-α level of the BSS group was the highest among the three (P<0.01)

followed by the BDS and the WHS groups. The expression profiles of cytokines in the circulation might not be necessarily identical for psoriatic patients with different CM syndromes. Accordingly

the serum concentrations of certain cytokines could potentially be used as the ancillary indices for the clinical classification of psoriatic CM syndromes.

Abstract

blood-dryness syndrome (BDS) and wind-heat syndrome (WHS)]. A total of 62 psoriatic patients were recruited and assigned to 3 groups according to their CM syndromes

including 27 patients of BSS

21 of BDS and 14 of WHS. Another 20 sex- and age-matched healthy subjects were enrolled into the control group. Serum concentrations of multiple cytokines

including monocyte chemotactic protein-1 (MCP-1)

macrophage inflammatory protein-1α (MIP-1α)

soluble CD4O ligand (SCD40L)

tumor necrosis factor-α (TNF-α)

epidermal growth factor (EGF)

interleukin-8 (IL-8)

interleukin-17 (IL-17)

interferon γ inducible protein-10 (IP-10) and vascular endothelial growth factor (VEGF)

were measured by a multiplexed flow cytometric assay. The circulating levels of MIP-1α

TNF-α

IL-8

and IP-10 were significantly increased in the psoriatic patients compared with the healthy controls (P<0.01). Male and female patients tended to have higher serum levels of MCP-1 and IP-10

respectively (P<0.05). Interestingly

compared with the control group

6 out of the 9 cytokines (MCP-1

MIP-1α

TNF-α

EGF

IL-8 and IP-10) were substantially increased in the BSS group (P<0.05 or P<0.01)

whereas only MIP-1α and IL-8 levels were elevated in the BDS group (P<0.05 or P<0.01) concurrent with lowered concentrations of SCD40L and IL-17 (P<0.05). In the WHS group

MIP-1α was the only cytokine whose level was evidently increased (P<0.01)

TNF-α level of the BSS group was the highest among the three (P<0.01)

followed by the BDS and the WHS groups. The expression profiles of cytokines in the circulation might not be necessarily identical for psoriatic patients with different CM syndromes. Accordingly

the serum concentrations of certain cytokines could potentially be used as the ancillary indices for the clinical classification of psoriatic CM syndromes.

关键词

psoriasis vulgarisblood-stasis syndromeblood-dryness syndromewind-heat syndromecytokinesChinese medicine syndrome

Keywords

psoriasis vulgarisblood-stasis syndromeblood-dryness syndromewind-heat syndromecytokinesChinese medicine syndrome

references

Liu W, Zhao G, Liu YF. Proliferation response of peripheral blood mononuclear cells to streptococcus M6 protein in patients with psoriasis. J Fourth Milit Med Univ (Chin) 2003;24:1213–1215.

Skov L, Kragballe K, Zachariae C, Obitz ER, Holm EA, Jemec GB, et al. HuMax-CD4: a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris. Arch Dermatol 2003;139:1433–1439.

Bos WE, Thio HB, Neumann HA, van der Fits L, Prens EP. The pathogenesis of inflammatory dermatoses, expecially psoriasis. Ned Tijdschr Geneeskd 2006;150:179–183.

Krueger GG, Langley RG, Leonardi C, Yeilding N, Guzzo C, Wang Y, et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 2007;356:580–592.

Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005;11:43–49.

Deng BX, Jiang CY, Wang P, liu WL, Qu X, Zhao YM, et al. Rule of distribution and development of TCM syndromes of psoriasis. J Tradit Chin Med (Chin) 2006;47:770–772.

Zhang GZ, Wang P, Wang JS, Jiang CY, Deng BX, Li P, et al. Study on the distribution and development rules of TCM syndromes of 2651 psoriasis vulgaris cases. J Tradit Chin Med (Chin) 2008;49:894–896.

An JY, Jin L. Traditional Chinese medicine progress research of psoriasis with blood-stage treatment. Chin J Dermatovenerol Integr Tradit West Med (Chin) 2009;8:59–61.

Psoriasis Study Group, Skin Venereal Diseases Branch of Chinese Medical Association. Guideline for the treatment of psoriasis (2008). Chin J Dermatol (Chin) 2009;42:213–214.

Zheng XY, ed. Guiding principle of clinical research on new drugs of traditional Chinese medicine. Beijing: China Medical Science Press; 2002:229–300.

Wang L, Yang L, Gao L, Gao TW, Li W, Liu YF. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis. Int J Immunogenet 2008;35:45–49.

Kaur S, Zilmer K, Leping V, Zilmer M. Comparative study of systemic inflammatory responses in psoriasis vulgaris and mild to moderate allergic contact dermatitis. Dermatology 2012;225:54–61.

Szodoray P, Alex P, Chappell-Woodward CM, Madland TM, Knowlton N, Dozmorov I, et al. Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system. Rheumatology (Oxford) 2007;46:417–425.

Chen JS, Zheng M. Expression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in patients with psoriasis. Chin J Dermatol (Chin) 2002;35:111–113.

Jin L, Jiang YS, Cai NN, Wang P. Expression of VEGF in skin lesions and serum level in patients of psoriasis vulgaris with TCM differentiation-types. Chin J Derm Venereol (Chin) 2006;20:406–408.

Perera GK, Di Meglio P, Nestle FO. Psoriasis. Annu Rev Pathol 2012;7:385–422.

Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005;2005:273–279.

Takahashi H, Tsuji H, Hashimoto Y, Ishida-Yamamoto A, Iizuka H. Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 2010;35:645–649.

Cai Y, Shen X, Ding C, Qi C, Li K, Li X, et al. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity 2011;35:596–610.

Erturan I, Köroğlu BK, Adiloğlu A, Ceyhan AM, Akkaya VB, Tamer N, et al. Evaluation of serum SCD40L and homocysteine levels with subclinical atherosclerosis indicators in patients with psoriasis: a pilot study. Int J Dermatol 2014;53:503–509.

Gerdes S, Osadtschy S, Buhles N, Baurecht H, Mrowietz U. Cardiovascular biomarkers in patients with psoriasis. Exp Dermatol 2014;23:322–325.

Witowski J, Ksiazek K, Jörres A. Interleukin-17: a mediator of inflammatory responses. Cell Mol Life Sci 2004;61:567–579.

Zhang P, Zhang R, Zhou XY. The expression and significant of IL-17 in psoriatic lesions. Chin J Dermatovenereol (Chin) 2010;24:13–15.

Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005;64:ii30–36.

Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9–22.

Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, et al. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy. Br J Dermatol 2010;163:1282–1290.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

The diagnostic criteria of blood-stasis syndrome: Considerations for standardization of pattern identification

Yin-yang and Zheng: Exported from Chinese medicine

Application of metabolomics technology in the research of Chinese medicine

Analysis on the Chinese medicine syndromes and demographic characteristics of patients with influenza-like illness in clinics of China

Exploring molecular mechanism underlying Chinese medicine syndrome: A study on correlation between Chinese medicine syndrome and biomarkers for ischemic stroke

Related Author

No data

Related Institution

Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences

Graduate School, Beijing University of Chinese Medicine

Department of Pediatrics, Indiana University School of Medicine

Department of Otolaryngology, Indiana University School of Medicine

Key Laboratory of Traditional Chinese Medicine Resource and Compoumd Prescription of the Ministry of Education, Hubei University of Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰